Where it Started
Dr. Khalid El Sayed is the inventor of Oleolive's patented technology a co-founder of the company and a medicinal chemist. He is one of (if not, the most) published researchers in the field of Extra Virgin Olive Oil phenolics and an expert on oleocanthal. His discoveries have advanced our understanding of oleocanthal's mechanism of action, safety profiles, myriad health benefits and much more.
Dr. Kaddoumi has been with us since the beginning and was one of the first researchers to explore the cognitive enhancement benefits associated with consuming oleocanthal. She is a widely published figure in the field of Extra Virgin Olive Oil phenolics and has run multiple clinical trials assessing the effect of oleocanthal and its constituents on neurodegenerative diseases.
Where We're at Now
Oleolive, the parent company of Oligen, started in 2019 with the mission to find overlooked biotechnologies and bring them to the market. The first technology (which is reflected in our name) was a process to extract oleocanthal and oleacein in a a scalable way from polyphenol rich extra virgin olive oil (EVOO). In the beginning, we received support from the National Institutes of Health and studied the benefits of oleocanthal consumption. We built out our own production facility in the USA, and now make all of our products ourselves with our small team of dedicated researchers, technicians and laboratory professionals. Every product we produce follows current Good Manufacturing Practices (cGMPs) as well as ISO 9001 guidelines. We take extreme pride in producing the highest quality and trust level products possible.
Our Story
Oleolive, the makers of Oligen, is not a supplement or marketing company, we are a biotech company doing cutting edge research on serious diseases. We develop therapeutics for neurodegenerative diseases and rare cancers. We took this insanely high standard and applied it to the development of Oligen. Oligen has been thoroughly researched in a wide array of models from in vitro to in vivo and even clinically as oleocanthal. There are hundreds of peer reviewed and published papers on the benefits of oleocanthal consumption and we are continually looking to improve the field. Our motto since inception has been "Science First" and we stuck to it, taking four years to fully develop and commercialize our product, now known as Oligen.
Our Brand
As we developed Oligen, we kept a few things in mind that were important to us as a company and important to our customers. With a commitment to simplicity, Oligen boasts a carefully curated blend of four key ingredients. Firstly, our active component is a patented extract of extra virgin olive oil, produced in-house with water as the primary solvent, ensuring the delivery of the natural compound in its purest form.